John Mascarenhas, MD: So JAK inhibitors are a class of agents. They’re oral agents. There are probably at least a dozen that have been in clinical development. And what they do is potently inhibit a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback